Spiriva Respimat 5 mcg did not achieve superiority to Spiriva Handihaler with a similar time to first COPD exacerbation (hazard ratio of 0.98 [95% CI, 0.93-1.03]). Asthma.

In this randomized, double-blind, parallel-group trial involving 17,135 patients with COPD, we evaluated the safety and efficacy of tiotropium Respimat at a once-daily dose of 2.5 μg or 5 μg, as ...

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

Spiriva Respimat, as an add-on to inhaled corticosteroids or long-acting beta2 agonists, reduced the risk for severe asthma exacerbation in patients across severities of symptomatic asthma and a ...

As recently as March, Dutch researchers reported a nearly 30% increase in mortality with tiotropium Respimat, compared with tiotropium HandiHaler (Eur Respir J. 2013;42:606-615 ).

SPIRIVA RESPIMAT, 1.25 mcg, is a long-term, once-daily, prescription maintenance treatment of asthma for people 6 years and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms ...

SPIRIVA RESPIMAT, 2.5 mcg, is a long-term, once-daily, prescription maintenance medicine used to control symptoms of chronic obstructive pulmonary disease (COPD) ...

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray ...

Philadelphia, Pennsylvania 21 st May, 2013 – In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMist TM Inhaler increases time to ...

The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years and older, according to a manufacturer press release.“The [FDA] approval of Spiriva ...

Spiriva Respimat only comes as a brand-name drug. It’s not currently available in a generic version. A generic contains an exact copy of the active drug in a brand-name medication.

SAN ANTONIO, Texas--(BUSINESS WIRE)--Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic ...